Acrivon Therapeutics, Inc.
ACRV · Pharmaceutical Preparations8
Directors
55
Avg Age
4.8
Avg Tenure (yrs)
75%
Independent
Independent
Non-independent
Near rotation
Board Members
PP
Peter Blume-Jensen, M.D., Ph.D.
Chair
KM
Kristina Masson, Ph.D., M.B.A.
Director
...and 6 more directors
The full roster, committee assignments, director pay, and expected-turnover signals for every board on the site are in our free newsletter, Seats Opening.
Get Seats OpeningSource: SEC DEF 14A proxy statement filed 2026-04-30. Data extracted and structured by FindABoardSeat.